from-the-market
FDA takes aim at "unproven" HCG weight-loss brands (Reuters)
December 6, 2011 by publisher · Leave a Comment
Reuters – Regulators have taken first steps to remove from the market over-the-counter products containing HCG hormone, saying the homeopathic formulations fraudulently claim to produce weight loss and may pose serious health risks.
Originally posted here:
FDA takes aim at "unproven" HCG weight-loss brands
(Reuters)
from-the-market
Abbott diet drug study renews calls for U.S. ban (Reuters)
September 2, 2010 by admin · Leave a Comment
Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
Originally posted here:
Abbott diet drug study renews calls for U.S. ban
(Reuters)
from-the-market
Abbott’s diet drug study renews calls for U.S. ban (Reuters)
September 2, 2010 by publisher · Leave a Comment
Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
Original post:
Abbott’s diet drug study renews calls for U.S. ban
(Reuters)

